SPIA
RVMD icon

Steward Partners Investment Advisory’s Revolution Medicines RVMD Stock Holding History

Steward Partners Investment Advisory’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$71.1K Buy
731
+2
+0.3% +$202 ﹤0.01% 2587
2025
Q4 		$58.1K Sell
729
-50
-6% -$3.28K ﹤0.01% 2595
2025
Q3 		$36.4K Buy
+779
New +$30.5K ﹤0.01% 2764
2025
Q1 		– Sell
-450
Closed -$19.7K – 4139
2024
Q4 		$19.7K Buy
+450
New +$22.7K ﹤0.01% 2807
2021
Q2 		– Sell
-125
Closed -$5.74K – 7350
2021
Q1 		$5.74K Buy
+125
New +$5.61K ﹤0.01% 2980

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Steward Partners Investment Advisory's RVMD Position: Q1 2026 in Review

Steward Partners Investment Advisory increased its Revolution Medicines (RVMD) stake by 0.27% in Q1 2026, buying an estimated $202 and bringing the position to 731 shares worth $71.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2587.

Steward Partners Investment Advisory first reported a position in RVMD in Q1 2021 and has held it in 5 quarters since. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Steward Partners Investment Advisory held 731 shares of Revolution Medicines worth $71.1K as of Q1 2026.
  • Steward Partners Investment Advisory bought 2 Revolution Medicines shares in Q1 2026, an estimated $202.
  • Revolution Medicines made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #2587 holding.
  • Steward Partners Investment Advisory first reported a position in Revolution Medicines in Q1 2021 and has held it in 5 quarters since.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.